Figures & data
Figure 1. Flow chart. COPD: Chronic Obstructive Pulmonary Disease; ICS: Inhaled Corticosteroid; LAMA: Long-Acting Muscarinic Antagonist; LABA: Long-Acting β2-Agonist.
![Figure 1. Flow chart. COPD: Chronic Obstructive Pulmonary Disease; ICS: Inhaled Corticosteroid; LAMA: Long-Acting Muscarinic Antagonist; LABA: Long-Acting β2-Agonist.](/cms/asset/34f4aff7-5403-4901-a64c-2f6aaa38cd6b/iann_a_2192519_f0001_b.jpg)
Table 1. Baseline characteristics of the total less symptomatic COPD patients.
Table 2. Description of inhalation therapy.
Table 3. The clinical characteristics of different inhalation therapies on less symptomatic COPD patients.
Table 4. Exacerbation and mortality during one year of follow-up of different inhalation therapies on less symptomatic COPD patients.
Table 5. Exacerbation and mortality during one year of follow-up of different inhalation therapies on Groups A and C patients.
Supplemental Material
Download MS Word (39.6 KB)Data availability statement
All data of this study are available from the corresponding author Ping Chen for reasonable request.